BIO Double Helix Sponsor
Sponsors

Company Profile

Travanti Pharma Inc.

Drug Delivery

2520 Pilot Knob Road
Suite 100
Mendota Heights, MN 55120
USA
www.travantipharma.com 		Incorporated in 1997
15 Employees 		Privately Held

This Year's Highlights

  • Successfully completed pre-IND meeting with FDA for Project Neon(internal devl.)- pre-clinical animal testing progressing well; successfully completed Phase I clinical trial with company's core technology (WEDD) in conjunction with external corp. partner.
  • Passed 2.5 million units sold of the Company's first marketed family of products - IontoPatch (R).
  • Completed a series of human and animal trials (several with corporate sponsors) demonstrating the breadth and efficacy of the Company's core technology (WEDD).

Anticipated Highlights

  • Initiation of Phase I clinical trial for the Company's first internal development program (Project Neon).
  • Initiation of Phase II clinical trial for the Company's second internal development program (Project Plutonium).
  • Initiation of pivotal Phase I trial for the Company's first licensed external program (Project Vanadium).

Corporate Mission

Travanti Pharma Inc. designs, develops and markets innovative drug delivery platforms that improve the safety, compliance, effectiveness and ease of administration of medication delivered into the body. Many drug delivery companies have been formed based upon an even greater number of technologies over the years. The successful companies among this group are the ones that, armed with a valuable and broad technology platform, have focused in the first instance on bringing individual products to market and reaping the financial rewards of this effort. Travanti is proceeding on such a path.